Klick Health Stacks Bench in London to Support Global Business Growth and Expansion
Klick Health today shared new details about the ongoing build-out of its global ecosystem, differentiated by its singular focus on health and improved patient outcomes, authentic integration modus operandi, and longstanding commitment to providing unmatched client experience. The large independent agency announced its UK-based leadership team for Europe, the Middle East, and Africa (EMEA). The news follows the appointment of EMEA Managing Director Jennifer Lambert and debut of Klick’s Asia-Pacific (APAC) hub in Singapore.
Lambert is joined in the London hub by industry veterans Ankita Batla, January Coyle, Preeti Moseman, Tara Page, Michael Smith, and Adrian Swift, as the team celebrates 13 wins at last week’s Creative Floor Awards and its stellar showing at the Cannes Lions International Festival of Creativity.
“We are thrilled to be building the most innovative life sciences agency model EMEA has ever seen. While most global agencies tend to force-fit their services together, Klick teams are integrated from the start. Based on our clients’ needs, we provide them with bespoke end-to-end services to ensure authentic and borderless solutions,” Lambert said. “I am proud of the work our team is doing. In Preeti, Tara, Michael, Adrian, Ankita, and January, we have proven leaders from both the agency and client side, who deliver solutions that amplify our clients’ success.”
Lambert introduced Klick’s EMEA leadership team:
Preeti Moseman – Senior Creative Lead, EMEA
Moseman marks her return to the UK as Senior Creative Lead in London, following two years serving as a Creative Director on Klick’s New York team. An award-winning creative with over 16 years of industry experience, Moseman previously held positions at London agencies, EG+ (TBWA) and Wunderman, where she worked for a range of clients, including GSK, Johnson & Johnson, Pepsico, and Microsoft. Within the healthcare sector specifically, she has played senior creative roles on global launches in immunology, vaccines, and women’s health.
“I joined Klick because its drive for innovation aligns with my passion for crafting engaging experiences,” Moseman said. “With a multitude of diverse, global perspectives and reach, Klick offers the perfect stage to foster creativity, build impactful cross-functional teams, and collaborate on successful campaigns for our clients.”
Tara Page – Vice President, Head of Client Success, EMEA
Heading up Klick’s UK-based Client Success team, Page is a veteran healthcare communications professional with over 25 years in the field, and is responsible for delivering an exceptional end-to-end client experience. Prior to joining Klick, Page was Global Director, Client Engagement at VMLY&R Health London, preceded by Managing Director, Sudler London, where she collaborated with top-tier pharmaceutical and biotech companies across brand lifecycles, covering therapeutic areas including, cardiovascular, hematology, oncology, and rare diseases.
“Being part of building a global life sciences agency from the ground-up and being surrounded by exceptionally kind and talented people is incredibly exciting. I’m loving the collaborative environment and the bright minds at Klick, as we work with our clients to enhance health outcomes and patients’ lives in EMEA and around the world,” explained Page.
Michael Smith – Science & Regulatory Director, EMEA
Bringing more than 17 years of experience leading in-house regulatory and healthcare compliance teams at pharmaceutical companies, Smith joins the agency world as Klick’s newest Science & Regulatory Director, EMEA. He previously served as Allergan's Director of Regulatory Affairs for the UK and Ireland. Smith has worked across aesthetic medicine, cosmetics, dermatology, medical devices, movement disorders, neurosciences, ophthalmology, and OTC, with extensive experience in UK, EU, and EMEA regulations to help ensure HCP and consumer-focussed campaigns are compliant. Smith excels in managing the complex requirements of healthcare compliance, ensuring creative teams are able to push boundaries and exceed expectations, while maintaining promotional compliance.
“I was drawn to the Klick’s team enthusiasm, professionalism, and regulatory rigour,” Smith said. “I’m excited for the opportunity to build our UK-based science and regulatory team, and serve our clients as part of the single, largest medical team integrated across a full-service agency.”
Adrian Swift – Vice President, Project Management, EMEA
With over 20 years of experience in delivery and project management roles, Swift joins Klick as Vice President, Project Management, EMEA. A seasoned leader who has worked on brands, including Coca-Cola, Centrica, and Unilever, he is adept in agile processes and managing projects for timely delivery. During his previous role as Managing Partner and EMEA PMO at Ogilvy, Swift worked on large accounts like IBM, Nestle, and The Nightingale Hospital, and led the agency’s consolidation of three regional markets into a global hub. One of his proudest career highlights was leading the team who helped expedite the establishment of temporary hospitals in the UK during the pandemic.
“My ultimate professional goal has always been to create a meaningful impact. Joining Klick and contributing to the development of something great in EMEA is an incredible opportunity to do so,” Swift said. “I’m thrilled to be part of a company that has a true entrepreneurial spirit and unique workplace culture, and eager to share my expertise in fostering agile mindsets to ensure our clients’ success.”
To further support Klick’s ongoing global expansion, Lambert also shared the following additions to the London-based team:
Ankita Batla, MBBS, MBA – Senior Vice President, Medical Strategy, Global
With over two decades of experience in patient engagement, health communications, and medical strategy, as well as a medical degree and an MBA, Dr. Batla specializes in research, strategy, and behaviour-change communication within pharmaceuticals, nutrition, health services, and public health and patient groups. As Klick’s Senior Vice President, Medical Strategy, Global, she focuses on the medical strategy needs of Klick’s growing number of international clients. She has also held senior medical roles at other UK-based agencies, including VMLY&R Health and WPP’s System Analytic. Prior to moving into healthcare communications, Dr. Batla served as a resident doctor in hospitals’ general medicine, pediatrics, public health, and neurology departments. As a leading expert in patient advocacy, she has served as a guest lecturer at top educational institutions in the UK, including the London School of Hygiene & Tropical Medicine, UCL Business School for Health UK, and University of West London. She is currently also pursuing her Masters degree in public health.
“A doctor by training and a patient advocate at heart, I love making connections between the numbers in science and the lived realities of people. At Klick, I have a work family that believes in this ethos,” Dr. Batla said. “Having worked and lived in different parts of the world has also given me a unique perspective in tackling health challenges and inequities across markets, and developing innovative creative strategies that can maximise access”
January Coyle – Senior Vice President, Global Strategy Enablement
Playing a key role on Klick Health’s holistic Strategy leadership team, Coyle joins its London hub as Senior Vice President, Global Strategy Enablement to ensure the effective coordination of strategy across Klick’s global markets and regions in EMEA, APAC, and LATAM. With over 20 years of experience in life sciences market research, KOL consulting, and advertising, Coyle most recently led a strategy team in Klick’s New York office for over three years. She previously served as Saatchi & Saatchi Wellness Senior Vice President, Director of Engagement Strategy for over six years. She has worked with a wide range of brands from pre-launch through LOE across therapeutic areas that include cardiovascular, metabolic, rare disease, and oncology, focussing on reaching key stakeholders in novel and engaging ways.
“It was the people and people-first culture that initially brought me to Klick. Now, I'm beyond excited to help scale the Klick magic in other markets and drive meaningful experiences for HCPs, patients, and their involved loved ones in partnership with our clients.”
Global momentum going strong
Today's announcement follows Klick joining the Healthcare Communications Council (HCC), one of the five European Association of Communications Agencies (EACA) councils, and it highlights the latest in a long line of global hires over the last year, as the agency continues to expand across APAC, EMEA, and LATAM. In June, Klick welcomed veteran agency leaders Mitchell Tan, Dr. Shraddha Tawate, Dr. Nevil Chimon, and Alvin Yeo to its APAC hub in Singapore.
“We are energized by our global momentum and how EMEA clients are responding to our unique agency model, end-to-end offerings, and success-driven approach,” Klick Health President Ari Schaefer said. “We’re excited by what the future holds.”
About Klick Health
Klick Health is the world’s largest independent commercialization partner for life sciences. For over 25 years, Klick has been laser-focused on developing, launching, and supporting life sciences brands to maximize their full market potential as a core commercialization partner. Recognized by leading global advertising authorities, Klick was named 2023 Independent Agency of the Year by Clio Health; its work has also been celebrated by Cannes Lions, D&AD, The One Show, Art Directors Club, Clios, New York Festivals Health, and the Webbys. Follow Klick Health on LinkedIn and for more information on joining Klick, go to careers.klick.com.
About Klick Group
The Klick Group of companies–Klick Health (including Klick Katalyst and btwelve), Klick Media Group, Klick Applied Sciences (including Klick Labs), Klick Consulting, Klick Ventures, and Sensei Labs–is an ecosystem of brilliant talent collectively working to maximize their people’s and clients’ full potential. Established in 1997, Klick has teams across North America, with offices in New York, Philadelphia, Toronto; global hubs in London, São Paulo, and Singapore; and plans to open more offices in Basel, Buenos Aires, Munich, Paris, and Tokyo. Klick has consistently been named a Best Managed Company and Great Place to Work. Over the last two years alone, the company has been recognized with almost 30 Best Workplace awards, including Best Workplaces for Women, Best Workplaces for Inclusion, Most Admired Corporate Cultures, Fast Company’s Best Workplaces for Innovators, FORTUNE’s Best Workplaces in New York, and FORTUNE’s Best Workplaces in Advertising.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230919111057/en/
Contact information
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
New Published Data Confirms Nemluvio ® (Nemolizumab) Can Rapidly Relieve Itch and Improve Sleep in as Early as Two Days in Both Atopic Dermatitis and Prurigo Nodularis17.12.2025 07:00:00 CET | Press Release
Galderma (SIX: GALD), the pure-play dermatology category leader, today released new clinical data confirming nemolizumab’s rapid onset of action on itch and sleep, with significant improvements observed as early as 48 hours after treatment in some patients with atopic dermatitis and prurigo nodularis.1 The findings from post-hoc analyses of the phase III ARCADIA and OLYMPIA clinical trial programs were published in the Journal of the European Academy of Dermatology and Venereology. Nemolizumab is the first approved monoclonal antibody that specifically targets IL-31 receptor alpha, inhibiting the signalling of IL-31.2,5,6 IL-31 is a neuroimmune cytokine that drives itch and other symptoms in both atopic dermatitis and prurigo nodularis.3,4 These new findings reinforce the critical role of IL-31 pathway inhibition in achieving rapid itch response. Atopic dermatitis and prurigo nodularis are debilitating skin conditions that significantly affect quality of life, with symptoms such as per
Mori Memorial Foundation’s Global Power City Index 2025 Sees City Rankings Shift Due to Tourism Gains in East Asia and Inflationary Pressures in the West17.12.2025 04:00:00 CET | Press Release
The Mori Memorial Foundation’s Institute for Urban Strategies, a research body established by Mori Building, Tokyo’s leading urban landscape developer, today published its annual Global Power City Index (GPCI) 2025, a report evaluating the urban competitiveness of 48 major cities worldwide. The report also includes the GPCI–Financial Centers index, an assessment of cities as international financial centers, and the new GPCI–Startup Ecosystems index, which assesses the competitiveness of startup environments. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251216187692/en/ 48 Major Cities Evaluated in Mori Memorial Foundation’s GPCI-2025 Report This year’s report highlights the remarkable rise of East Asian cities and the stagnation of several Western cities, showing how global challenges, such as geopolitical tensions and regional disparities in inflation, are greatly impacting the performance of major cities worldwide. The r
GE HealthCare and Indonesia’s Ministry of Health to expand access to quality care through the provision of 300+ advanced CT scanners17.12.2025 03:00:00 CET | Press Release
GE HealthCare (Nasdaq: GEHC) today announced it will supply more than 300 CT (computed tomography) scanners under Indonesia’s Strengthening Indonesia’s Health Referral Network (SIHREN) program to deliver equitable, high-quality care to more than 280 million Indonesians. As part of a competitively awarded, multi-year contract, GE HealthCare will supply the advanced CT scanners to public hospitals across all 38 provinces, including urban and remote areas. The CT scanner procurement under SIHREN was conducted through a fully competitive international tender process governed by the World Bank’s procurement regulations. SIHREN is the largest healthcare infrastructure investment in Indonesia’s history and among the largest multilateral health projects globally. SIHREN aims to modernize the national referral system and expand access to diagnostics and treatment across the archipelago, with a focus on non-communicable diseases (NCD) management, maternal health, and pandemic resilience. By mode
IDWS 2025 Concludes with Focus on Global Knowledge Exchange, Financial Opportunities, and Scalable Water Solutions16.12.2025 20:03:00 CET | Press Release
The 4th Innovation Driven Water Sustainability Conference (IDWS) 2025 concluded on Wednesday in Jeddah, confirming its status as one of the world’s most influential platforms for shaping the future of water innovation, sustainability, and security. Gathering senior global policymakers and international industry leaders, this year’s edition has advanced critical dialogue on safeguarding the planet’s most vital resource, with Saudi Arabia at the forefront. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251216483490/en/ Investors, innovators, and global institutions gather in Saudi to outline how capital, collaboration, and governance can accelerate long term water sustainability (Photo: AETOSWire) Among the most consequential engagements were a series of meetings that brought together discussions powered by SWA, centred on shared challenges, knowledge exchange, and exploring opportunities within the global water ecosystem. Att
OAG Appoints ex-Skyscanner Executive Filip Filipov as New Chief Executive Officer16.12.2025 17:00:00 CET | Press Release
OAG announces today the appointment of Filip Filipov, ex-Skyscanner executive, as new Chief Executive Officer. Filip Filipov currently serves as the company’s Chief Operating Officer and takes over from Phil Callow who has chosen to step down having completed thirteen transformational years at the helm of OAG to pursue his many other interests. Since joining in 2024, Filipovhas played a leading role in the company’s ambitious next phase of growth and ongoing acceleration. He will now lead OAG into a new era defined by advanced data products and AI-driven intelligence. Before joining OAG, Filipov held senior roles in travel technology and big-data consulting, including on Skyscanner’s executive team. Filip Filipov said: “It’s a privilege to step into this role and lead a company with such a strong heritage and reputation. I’m excited for what’s ahead and committed to serving our customers with the reliability, service, and innovation they depend on.” Chairman of OAG, Gehan Talwatte, com
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
